Literature DB >> 15942172

Lacunar infarcts: functional and cognitive outcomes at five years in relation to MRI findings.

Peter Appelros1, Margareta Samuelsson, Dan Lindell.   

Abstract

BACKGROUND: There are few long-term follow-up studies of patients with lacunar infarcts (LIs). The purpose of this 5-year follow-up study was to assess functional and cognitive outcome in relation to MRI findings.
METHODS: 81 patients with a first-ever LI were followed for 5 years with respect to mortality, stroke recurrence, functional and cognitive outcome. T(2)-weighted MRI was performed at baseline and at 5 years. The presence of basal ganglia lesions and white matter lesions was scored according to the European Task Force rating scale. Functional outcome was assessed with the Oxford Handicap Scale (OHP). Cognition was assessed with the Mini Mental State Examination (MMSE).
RESULTS: The 5-year mortality was 19%. Predictors for death were age (OR = 1.07, 95% CI 1.03-1.11), ischemic heart disease (OR = 2.1, 95% CI 1.1-4.1) and impairment score (OR = 1.16, 95% CI 1.02-1.32). 30% of the patients had a recurrent stroke. Predictors for recurrent stroke were diabetes mellitus (OR = 1.7, 95% CI 1.2-7.4) and amount of white matter lesions (OR = 1.7, 95% CI 1.2-2.7). 36% of the patients were functionally dependent (defined as OHP >2). Predictors for functional dependency were impairment score (OR = 1.71, 95% CI 1.12-2.59), MMSE (OR = 0.55, 95% CI 0.33-0.91) and stroke recurrence (OR = 84, 95% CI 9.4-745). 16% of the patients had cognitive impairment (defined as MMSE <24). Stroke recurrence and white matter score, but not basal ganglia score, were correlated to cognitive impairment.
CONCLUSIONS: Many LI patients have a good functional outcome at 5 years. For older patients, for patients with an initial severe stroke, and with additional vascular risk factors, however, the prognosis is more severe, with an increased risk for mortality, stroke recurrence, and physical and cognitive decline. Copyright 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2005        PMID: 15942172     DOI: 10.1159/000086202

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  11 in total

1.  Administration of sesamol improved blood-brain barrier function in streptozotocin-induced diabetic rats.

Authors:  R L VanGilder; K A Kelly; M D Chua; R L Ptachcinski; Jason D Huber
Journal:  Exp Brain Res       Date:  2009-06-30       Impact factor: 1.972

2.  Self-perceptions on cognitive versus motor disability among neurologists.

Authors:  Shahed Toossi; Konrad H Schlick; Shouri Lahiri
Journal:  Neurol Sci       Date:  2019-11-28       Impact factor: 3.307

3.  Clinical Significance of Magnetic Resonance Imaging Markers of Vascular Brain Injury: A Systematic Review and Meta-analysis.

Authors:  Stéphanie Debette; Sabrina Schilling; Marie-Gabrielle Duperron; Susanna C Larsson; Hugh S Markus
Journal:  JAMA Neurol       Date:  2019-01-01       Impact factor: 18.302

Review 4.  Recent Advances in Leukoaraiosis: White Matter Structural Integrity and Functional Outcomes after Acute Ischemic Stroke.

Authors:  Mark R Etherton; Ona Wu; Natalia S Rost
Journal:  Curr Cardiol Rep       Date:  2016-12       Impact factor: 2.931

5.  European Stroke Organisation and European Academy of Neurology joint guidelines on post-stroke cognitive impairment.

Authors:  Terence J Quinn; Edo Richard; Yvonne Teuschl; Thomas Gattringer; Melanie Hafdi; John T O'Brien; Niamh Merriman; Celine Gillebert; Hanne Huyglier; Ana Verdelho; Reinhold Schmidt; Emma Ghaziani; Hysse Forchammer; Sarah T Pendlebury; Rose Bruffaerts; Milija Mijajlovic; Bogna A Drozdowska; Emily Ball; Hugh S Markus
Journal:  Eur Stroke J       Date:  2021-10-08

6.  Biological and imaging predictors of cognitive impairment after stroke: a systematic review.

Authors:  Barbara Casolla; François Caparros; Charlotte Cordonnier; Stéphanie Bombois; Hilde Hénon; Régis Bordet; Francesco Orzi; Didier Leys
Journal:  J Neurol       Date:  2018-10-22       Impact factor: 4.849

7.  White matter disease as a biomarker for long-term cerebrovascular disease and dementia.

Authors:  Aurauma Chutinet; Natalia S Rost
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-03

8.  Single and combined effects of cerebral white matter lesions and lacunar infarctions on cognitive function in an elderly population.

Authors:  Bernard T Baune; Andreas Roesler; Stefan Knecht; Klaus Berger
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-01-20       Impact factor: 6.053

9.  Structural neuroimaging of concomitant depressive symptoms in amnestic mild cognitive impairment: a pilot study.

Authors:  Jean-François Morin; Abderazzak Mouiha; Sandra Pietrantonio; Simon Duchesne; Carol Hudon
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2012-11-30

Review 10.  The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis.

Authors:  Stéphanie Debette; H S Markus
Journal:  BMJ       Date:  2010-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.